ANN ARBOR, Mich., Oct. 27, 2008 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading regenerative medicine company, today announced that shareholders of the Company approved all fiscal year 2008 proxy proposals at the Annual Meeting of Shareholders held October 17, 2008. After tabulating the votes, Broadridge Financial Solutions, Inc. reported that approximately 107 million shares, or approximately 81% of the shares outstanding on the record date, were represented at the Annual Meeting, in person or by proxy. Aastrom had approximately 133 million shares outstanding on the record date of September 2, 2008.
